Journal article icon

Journal article

Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)

Abstract:
Objective Report results from PERSIST, a real-life, observational, prospective cohort study of CT-P13, an infliximab (IFX) biosimilar, for treatment of patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) or psoriatic arthritis (PsA) who were biologic-naïve or switched from IFX reference product (IFX-RP; Remicade®).
Methods Adult patients were recruited during usual care at 38 sites in Europe and Canada, and enrolled by their physicians a... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1093/rap/rkab026

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Botnar Research Centre
Role:
Author
ORCID:
0000-0001-7766-6167
Expand authors...
Publisher:
British Society for Rheumatology Publisher's website
Journal:
Rheumatology Advances in Practice Journal website
Volume:
5
Issue:
2
Publication date:
2021-04-23
Acceptance date:
2021-03-16
DOI:
EISSN:
2514-1775
Language:
English
Keywords:
Pubs id:
1175654
Local pid:
pubs:1175654
Deposit date:
2021-05-13

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP